Search Results for: MAPK8

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel ETV1 ETS variant transcription factor 1
  • Prostate cancer
  • Ewing's sarcoma
Novel FAM193B family with sequence similarity 193 member B
Novel FZR1 fizzy and cell division cycle 20 related 1
  • Autodegradation of Cdh1 by Cdh1:APC/C
  • SCF-beta-TrCP mediated degradation of Emi1
  • APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
  • Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase
  • Regulation of APC/C activators between G1/S and early anaphase
  • Phosphorylation of Emi1
  • Senescence-Associated Secretory Phenotype (SASP)
  • Assembly of the pre-replicative complex
  • CDK-mediated phosphorylation and removal of Cdc6
  • Cyclin A/B1/B2 associated events during G2/M transition
  • Cyclin A:Cdk2-associated events at S phase entry
  • Transcriptional Regulation by VENTX
  • Aberrant regulation of mitotic exit in cancer due to RB1 defects
  • Antigen processing: Ubiquitination & Proteasome degradation
Novel GANAB glucosidase II alpha subunit
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Calnexin/calreticulin cycle
  • Maturation of spike protein
  • Maturation of spike protein
  • Regulation of CDH1 posttranslational processing and trafficking to plasma membrane
  • Miglitol
Novel GARS1 glycyl-tRNA synthetase 1
  • Cytosolic tRNA aminoacylation
  • Mitochondrial tRNA aminoacylation
  • Glycine
  • Charcot-Marie-Tooth disease (CMT); Hereditary motor and sensory neuropathy; Peroneal muscular atrophy
  • Distal hereditary motor neuropathies (dHMN)
Novel GDF10 growth differentiation factor 10
Novel GEMIN5 gem nuclear organelle associated protein 5
  • snRNP Assembly
  • SARS-CoV-2 modulates host translation machinery
Novel GFPT1 glutamine--fructose-6-phosphate transaminase 1
  • XBP1(S) activates chaperone genes
  • Defective GFPT1 causes CMSTA1
  • Synthesis of UDP-N-acetyl-glucosamine
Novel GORASP2 golgi reassembly stacking protein 2
  • Golgi Cisternae Pericentriolar Stack Reorganization
Novel GPRIN2 G protein regulated inducer of neurite outgrowth 2
Novel GSTP1 glutathione S-transferase pi 1
  • Glutathione conjugation
  • Detoxification of Reactive Oxygen Species
  • Neutrophil degranulation
  • Paracetamol ADME
  • Glutathione
  • Troglitazone
  • Clozapine
  • Etacrynic acid
  • Clomipramine
  • (9R,10R)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene
  • S-Hydroxycysteine
  • Cibacron Blue
  • Glutathione sulfonic acid
  • Glutathione disulfide
  • Deoxycholic acid
  • Deoxycholic acid
  • S-(4-nitrobenzyl)glutathione
  • 2-(N-morpholino)ethanesulfonic acid
  • S-Hexylglutathione
  • Canfosfamide
  • Ezatiostat
  • Exisulind
  • S-NONYL-CYSTEINE
  • S-(4-BROMOBENZYL)CYSTEINE
  • Curcumin
  • Dinitrochlorobenzene
  • Hypericin
  • Curcumin sulfate
  • Prostate cancer
Novel GUCY1A1 guanylate cyclase 1 soluble subunit alpha 1
  • Nitric oxide stimulates guanylate cyclase
  • Smooth Muscle Contraction
  • Smooth Muscle Contraction
  • Isosorbide
Novel H2AX H2A.X variant histone
  • Recognition and association of DNA glycosylase with site containing an affected pyrimidine
  • Cleavage of the damaged pyrimidine
  • Recognition and association of DNA glycosylase with site containing an affected purine
  • Recognition and association of DNA glycosylase with site containing an affected purine
  • Cleavage of the damaged purine
  • Cleavage of the damaged purine
  • Meiotic synapsis
  • Packaging Of Telomere Ends
  • Pre-NOTCH Transcription and Translation
  • Formation of the beta-catenin:TCF transactivating complex
  • Formation of the beta-catenin:TCF transactivating complex
  • PRC2 methylates histones and DNA
  • Condensation of Prophase Chromosomes
  • Oxidative Stress Induced Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • DNA Damage/Telomere Stress Induced Senescence
  • RMTs methylate histone arginines
  • SIRT1 negatively regulates rRNA expression
  • ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression
  • NoRC negatively regulates rRNA expression
  • NoRC negatively regulates rRNA expression
  • B-WICH complex positively regulates rRNA expression
  • DNA methylation
  • Transcriptional regulation by small RNAs
  • Activation of anterior HOX genes in hindbrain development during early embryogenesis
  • Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3
  • Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
  • Nonhomologous End-Joining (NHEJ)
  • Processing of DNA double-strand break ends
  • Deposition of new CENPA-containing nucleosomes at the centromere
  • Assembly of the ORC complex at the origin of replication
  • G2/M DNA damage checkpoint
  • RNA Polymerase I Promoter Opening
  • RNA Polymerase I Promoter Escape
  • RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
  • RUNX1 regulates transcription of genes involved in differentiation of HSCs
  • Estrogen-dependent gene expression
  • Meiotic recombination
  • Transcriptional regulation of granulopoiesis
  • Inhibition of DNA recombination at telomere
  • Defective pyroptosis
  • Negative Regulation of CDH1 Gene Transcription
  • Amyloid fiber formation
  • Chromatin modifications during the maternal to zygotic transition (MZT)
  • Replacement of protamines by nucleosomes in the male pronucleus
  • MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
  • MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
  • Regulation of endogenous retroelements by KRAB-ZFP proteins
  • Regulation of endogenous retroelements by KRAB-ZFP proteins
  • Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex
  • Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex
  • Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs)
  • Regulation of PD-L1(CD274) transcription
Novel HDAC9 histone deacetylase 9
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Notch-HLH transcription pathway
  • Valproic acid
  • Valproic acid
  • Decitabine
  • Vorinostat
  • Belinostat
  • Romidepsin
  • Panobinostat
  • Phenylbutyric acid
  • Entinostat
  • Abexinostat
  • Givinostat
  • Pyroxamide
Novel HIVEP1 HIVEP zinc finger 1
Novel HRAS HRas proto-oncogene, GTPase
  • SOS-mediated signalling
  • Activation of RAS in B cells
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • SHC1 events in ERBB2 signaling
  • SHC1 events in ERBB4 signaling
  • Signaling by SCF-KIT
  • Signalling to RAS
  • p38MAPK events
  • p38MAPK events
  • GRB2 events in EGFR signaling
  • SHC1 events in EGFR signaling
  • Downstream signal transduction
  • GRB2 events in ERBB2 signaling
  • GRB2 events in ERBB2 signaling
  • Tie2 Signaling
  • EGFR Transactivation by Gastrin
  • DAP12 signaling
  • SHC-related events triggered by IGF1R
  • FCERI mediated MAPK activation
  • NCAM signaling for neurite out-growth
  • EPHB-mediated forward signaling
  • Ras activation upon Ca2+ influx through NMDA receptor
  • VEGFR2 mediated cell proliferation
  • CD209 (DC-SIGN) signaling
  • Constitutive Signaling by EGFRvIII
  • SHC-mediated cascade:FGFR1
  • FRS-mediated FGFR1 signaling
  • SHC-mediated cascade:FGFR2
  • FRS-mediated FGFR2 signaling
  • SHC-mediated cascade:FGFR3
  • FRS-mediated FGFR3 signaling
  • FRS-mediated FGFR4 signaling
  • SHC-mediated cascade:FGFR4
  • Signaling by FGFR2 in disease
  • Signaling by FGFR4 in disease
  • Signaling by FGFR1 in disease
  • Signaling by FGFR3 in disease
  • Regulation of RAS by GAPs
  • RAF activation
  • RAF/MAP kinase cascade
  • MAP2K and MAPK activation
  • Negative regulation of MAPK pathway
  • Signaling by moderate kinase activity BRAF mutants
  • Signaling by high-kinase activity BRAF mutants
  • Signaling by BRAF and RAF1 fusions
  • RAS signaling downstream of NF1 loss-of-function variants
  • Paradoxical activation of RAF signaling by kinase inactive BRAF
  • Insulin receptor signalling cascade
  • PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
  • MET activates RAS signaling
  • Activated NTRK2 signals through RAS
  • Erythropoietin activates RAS
  • Activated NTRK2 signals through FRS2 and FRS3
  • Activated NTRK3 signals through RAS
  • FLT3 Signaling
  • Constitutive Signaling by Overexpressed ERBB2
  • Estrogen-stimulated signaling through PRKCZ
  • RAS processing
  • Signaling downstream of RAS mutants
  • Signaling by RAF1 mutants
  • Signaling by ERBB2 KD Mutants
  • Signaling by ERBB2 ECD mutants
  • Signaling by ERBB2 TMD/JMD mutants
  • Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants
  • Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants
  • Signaling by PDGFRA extracellular domain mutants
  • Signaling by FLT3 fusion proteins
  • Signaling by FLT3 ITD and TKD mutants
  • Signaling by RAS GAP mutants
  • Signaling by RAS GTPase mutants
  • Hexane-1,6-Diol
  • Trifluoroethanol
  • Guanosine-5'-Triphosphate
  • Guanosine-5'-Diphosphate
  • N,N'-DIMETHYL-N-(ACETYL)-N'-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE
  • Ursolic acid
  • Penile cancer
  • Cervical cancer
  • Noonan syndrome and related disorders, including: Noonan syndrome (NS); Leopard syndrome (LS); Noonan syndrome-like with loose anagen hair (NS/LAH); CBL-mutation associated syndrome (CBL); Neurofibromatosis type 1 (NF1); Neurofibromatosis type 2 (NF2); Neurofibromatosis-Noonan syndrome (NFNS); Legius syndrome; Cardiofaciocutaneous syndrome (CFCS); Costello syndrome (CS)
  • Hepatocellular carcinoma
  • Thyroid cancer
  • Squamous cell carcinoma
  • Bladder cancer
Novel HSD17B4 hydroxysteroid 17-beta dehydrogenase 4
  • Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
  • alpha-linolenic acid (ALA) metabolism
  • Beta-oxidation of pristanoyl-CoA
  • Beta-oxidation of very long chain fatty acids
  • Peroxisomal protein import
  • Peroxisomal protein import
  • TYSND1 cleaves peroxisomal proteins
  • NADH
  • (R)-3-hydroxydecanoyl-CoA
  • Peroxisomal beta-oxidation enzyme deficiency, including: Acyl-CoA oxidase (ACOX) deficiency; D-bifunctional protein (DBP) deficiency; Perrault syndrome; Sterol carrier protein X (SCPx) deficiency; 2-Methylacyl-CoA racemase (AMCR) deficiency; Hypercholanemia
Novel HSF1 heat shock transcription factor 1
  • Regulation of HSF1-mediated heat shock response
  • HSF1 activation
  • Attenuation phase
  • HSF1-dependent transactivation
  • Aggrephagy
  • Mitochondrial unfolded protein response (UPRmt)
  • Bimoclomol
Novel HSF4 heat shock transcription factor 4
Novel HSPA8 heat shock protein family A (Hsp70) member 8
  • Regulation of HSF1-mediated heat shock response
  • HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand
  • Attenuation phase
  • HSF1-dependent transactivation
  • Lysosome Vesicle Biogenesis
  • Golgi Associated Vesicle Biogenesis
  • CHL1 interactions
  • AUF1 (hnRNP D0) binds and destabilizes mRNA
  • Interleukin-4 and Interleukin-13 signaling
  • Neutrophil degranulation
  • mRNA Splicing - Major Pathway
  • Clathrin-mediated endocytosis
  • Protein methylation
  • GABA synthesis, release, reuptake and degradation
  • Lipophagy
  • Chaperone Mediated Autophagy
  • Late endosomal microautophagy
  • Respiratory syncytial virus genome transcription
  • PKR-mediated signaling
  • Dasatinib
  • (2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
  • Copper
  • Artenimol

Page 3 out of 15 pages